Clinical Trial Update: A Phase I Clinical Trial to Evaluate the Ebola Adenovirus Vector Vaccine (Ad5-EBOV) in Healthy Adults. [Phase 1]

View source ↗

Summary

A Phase I clinical trial evaluating the Ebola adenovirus vector vaccine Ad5-EBOV in healthy adults has completed, signaling early safety and immunogenicity data…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebola Virus Disease

Drugs mentioned

• Ad5-EBOV (Ebola adenovirus vector vaccine)

Snippet

Sponsor: Jiangsu Province Centers for Disease Control and Prevention | Conditions: Ebola Virus Disease | Phase 1 | Status: COMPLETED